What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cancer
His primary scientific interests are in Pulmonary embolism, Surgery, Venous thrombosis, Thrombosis and Internal medicine.
His Pulmonary embolism study combines topics from a wide range of disciplines, such as Observational study, Low molecular weight heparin, Heparin, Intensive care medicine and Venography.
His studies in Surgery integrate themes in fields like Cancer and Incidence.
His work deals with themes such as Respiratory disease, Anesthesia, Clinical trial, Randomized controlled trial and Radiology, which intersect with Venous thrombosis.
His study in Thrombosis is interdisciplinary in nature, drawing from both Anticoagulant and Colorectal cancer.
His research in Internal medicine intersects with topics in Gastroenterology and Cardiology.
His most cited work include:
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up (1132 citations)
- Low-molecular-weight heparin in the treatment of patients with venous thromboembolism (692 citations)
- Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. (670 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Pulmonary embolism, Surgery, Venous thromboembolism and Thrombosis.
His study in the field of Cancer, Confidence interval and Incidence also crosses realms of In patient.
Manuel Monreal combines subjects such as Odds ratio, Mortality rate, Hazard ratio, Low molecular weight heparin and Prospective cohort study with his study of Pulmonary embolism.
Much of his study explores Surgery relationship to Risk factor.
As part of the same scientific family, he usually focuses on Venous thromboembolism, concentrating on Intensive care medicine and intersecting with Randomized controlled trial and Clinical trial.
His research in Thrombosis tackles topics such as Radiology which are related to areas like Vein.
He most often published in these fields:
- Internal medicine (58.16%)
- Pulmonary embolism (56.73%)
- Surgery (38.16%)
What were the highlights of his more recent work (between 2018-2021)?
- Pulmonary embolism (56.73%)
- Internal medicine (58.16%)
- Venous thromboembolism (32.65%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Pulmonary embolism, Internal medicine, Venous thromboembolism, In patient and Thrombosis.
Pulmonary embolism is a primary field of his research addressed under Surgery.
Manuel Monreal focuses mostly in the field of Internal medicine, narrowing it down to matters related to Cardiology and, in some cases, Inferior vena caval and Concomitant.
His Venous thromboembolism research is multidisciplinary, relying on both Discontinuation, Lower risk, Increased risk, Heparin and Time course.
The study incorporates disciplines such as Anticoagulant, Randomized controlled trial, Intensive care medicine and Antithrombotic in addition to Thrombosis.
His work carried out in the field of Cancer brings together such families of science as Low molecular weight heparin and Venous thrombosis.
Between 2018 and 2021, his most popular works were:
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up (1132 citations)
- 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. (136 citations)
- Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. (90 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Cancer
His scientific interests lie mostly in Pulmonary embolism, Internal medicine, Thrombosis, Deep vein and Randomized controlled trial.
His studies deal with areas such as Logistic regression, Mortality rate, Emergency medicine, Stroke and Prospective cohort study as well as Pulmonary embolism.
Manuel Monreal has included themes like Epidemiology and Intensive care medicine in his Thrombosis study.
Surgery covers Manuel Monreal research in Deep vein.
In his study, which falls under the umbrella issue of Surgery, Propensity score matching and Recurrent thromboembolism is strongly linked to Lower risk.
His Randomized controlled trial study integrates concerns from other disciplines, such as Relative risk, Placebo, Extracorporeal membrane oxygenation and Antithrombotic.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
